eLIFEwithIBD: study protocol for a randomized controlled trial of an online acceptance and commitment therapy and compassion-based intervention in inflammatory bowel disease

Cláudia Ferreira, Joana Pereira, Inês Matos-Pina, David Skvarc, Ana Galhardo, Nuno Ferreira, Sérgio A. Carvalho, Paola Lucena-Santos, Bárbara S. Rocha, Sara Oliveira, Francisco Portela, Inês A. Trindade

Research output: Contribution to journalArticlepeer-review

Abstract

Background: Inflammatory bowel disease (IBD) entails physical, psychological, and social burden and holds a significant impact on quality of life. Experiential avoidance, cognitive fusion, shame, and self-criticism have been identified as possible therapeutic targets for improving mental health in people with IBD. Traditional face-to-face psychological therapy continues to provide obstacles for patients seeking assistance. Online psychological therapies centered on acceptance, mindfulness, and compassion have been shown to improve psychological distress in other populations. Objective: This paper presents the study protocol of a two-arm Randomized Controlled Trial (RCT) of an ACT and compassion-based, online intervention – eLIFEwithIBD - on the improvement of psychological distress, quality of life, work and social functioning, IBD symptom perception, illness-related shame, psychological flexibility, and self-compassion. Methods: The eLIFEwithIBD intervention is an adaptation of the LIFEwithIBD programme (delivered through an in-person group format) and entails an ACT, mindfulness, and compassion-based intervention designed to be delivered as an e-health tool for people with IBD. This protocol outlines the structure and contents of the eLIFEwithIBD intervention. Participants were recruited by an advertisement on the social media platforms of Portuguese Associations for IBD in January 2022. A psychologist conducted a brief interview with 80 patients who were interested in participating. Fifty-five participants were selected and randomly assigned to one of two conditions [experimental group (eLIFEwithIBD + medical TAU; n = 37) or control group (medical TAU; n = 18)]. Outcome measurement took place at baseline, post-intervention, and 4-month follow-up. All analyses are planned as intent-to-treat (ITT). Results: The eLIFEwithIBD intervention is expected to empower people with IBD by fostering psychological strategies that promote illness adjustment and well-being and prevent subsequent distress. The eLIFEwithIBD aims to gain a novel and better understanding of the role of online contextual behavioral interventions on improving the quality of life and mental health of people with IBD. Clinical Trial Registration: https://classic.clinicaltrials.gov/ct2/show/NCT05405855, NCT05405855.

Original languageEnglish
Article number1369577
Pages (from-to)1369577
JournalFrontiers in Psychology
Volume15
DOIs
Publication statusPublished - 9 Aug 2024

Bibliographical note

Copyright © 2024 Ferreira, Pereira, Matos-Pina, Skvarc, Galhardo, Ferreira, Carvalho, Lucena-Santos, Rocha, Oliveira, Portela and Trindade.

Funding

The author(s) declare that financial support was received for the research, authorship, and/or publication of this article. This project (CENTRO-01-0145-FEDER-028602|PTDC/PSI-ESP/28602/2017) was funded by the Fundo Europeu de Desenvolvimento Regional (FEDER) of the European Union, through the Programa Operacional Regional do Centro (CENTRO 2020) of Portugal-2020 and by the Funda\u00E7\u00E3o para a Ci\u00EAncia e Tecnologia I.P./MCTES through national funds (PIDDAC).

FundersFunder number
Fundação para a Ciência e a Tecnologia
Programa Operacional Regional do Centro
European Commission
European Regional Development Fund
Ministério da Ciência, Tecnologia e Ensino Superior

    Keywords

    • acceptance and commitment therapy
    • compassion
    • inflammatory bowel disease
    • mindfulness
    • randomized controlled trial
    • study protocol

    Fingerprint

    Dive into the research topics of 'eLIFEwithIBD: study protocol for a randomized controlled trial of an online acceptance and commitment therapy and compassion-based intervention in inflammatory bowel disease'. Together they form a unique fingerprint.

    Cite this